These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11411770)

  • 21. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
    Matrougui K; Lévy BI; Henrion D
    Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.
    Amiri F; Ko EA; Javeshghani D; Reudelhuber TL; Schiffrin EL
    J Hypertens; 2010 Jun; 28(6):1243-51. PubMed ID: 20308920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin in hypertension.
    Schiffrin EL
    Curr Opin Cardiol; 1995 Sep; 10(5):485-94. PubMed ID: 7496057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of endothelin-1 in human hypertension.
    Shreenivas S; Oparil S
    Clin Hemorheol Microcirc; 2007; 37(1-2):157-78. PubMed ID: 17641406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension.
    Schiffrin EL; Deng LY; Sventek P; Day R
    J Hypertens; 1997 Jan; 15(1):57-63. PubMed ID: 9050971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
    J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
    Watts SW; Fink GD; Northcott CA; Galligan JJ
    Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats.
    Alrashdi SF; Deliyanti D; Wilkinson-Berka JL
    Exp Eye Res; 2018 Nov; 176():1-9. PubMed ID: 29944850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of endothelin in human hypertension.
    Touyz RM; Schiffrin EL
    Can J Physiol Pharmacol; 2003 Jun; 81(6):533-41. PubMed ID: 12839265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY; Schiffrin EL
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
    Jesmin S; Zaedi S; Maeda S; Togashi H; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):919-24. PubMed ID: 16741024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin: potential role in hypertension and vascular hypertrophy.
    Schiffrin EL
    Hypertension; 1995 Jun; 25(6):1135-43. PubMed ID: 7768553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats.
    Li JS; Knafo L; Turgeon A; Garcia R; Schiffrin EL
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H88-93. PubMed ID: 8760162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced G-protein coupled receptors-mediated contraction and reduced endothelium-dependent relaxation in hypertension.
    Li J; Cao YX; Liu H; Xu CB
    Eur J Pharmacol; 2007 Feb; 557(2-3):186-94. PubMed ID: 17204265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
    McCulloch KM; Docherty C; MacLean MR
    Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure.
    Pérez-Rivera AA; Fink GD; Galligan JJ
    Vascul Pharmacol; 2005 Jun; 43(1):1-10. PubMed ID: 15975530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.